MSF calls on ViiV to urgently dismantle barriers to access for long-acting cabotegravir Geneva, 29 November 2022 – Doctors Without Borders/Médecins Sans Frontières (MSF) today called on pharmaceutical corporation ViiV to urgently dismantle the barriers
Trying to see a doctor; getting hold of insulin treatment for diabetes; seeking legal advice prior to an asylum interview. All of these are a challenge for the refugees, migrants and asylum-seekers stuck in the
In 2002, Médecins Sans Frontières (MSF) teams opened the first outpatient treatment centre offering free care to people living with HIV in Kinshasa, the capital of the Democratic Republic of Congo (DRC). Twenty years later, while great progress
“We haven’t had enough time between one disaster and another.” Dr Asma Aweis Abdallah is the medical activity manager with Médecins Sans Frontières/Doctors Without Borders (MSF) in Baidoa, Somalia. Here she describes the situation the
Background: Tuberculosis is one of the leading causes of death worldwide and the main cause of mortality from a single infectious agent. In 2019 alone, approximately 1.4 million people died, and 465,000 fell ill with
Under the auspices of the global fight against the Islamic State (IS) group, exceptional policies have been implemented involving the indefinite and arbitrary detention of women, children and men in Al-Hol camp in northeast Syria. Médecins
Amsterdam/Al-Hol, Syria, 7 November 2022 – The deaths of two boys while awaiting approval for emergency medical care are just two of many tragic cases featured in a new report by Médecins Sans Frontières (MSF)
Geneva (MSF/ICRC) – Climate change is not a distant threat. It is already dramatically affecting vulnerable people across the globe. In particular, the changing climate is having devastating consequences for people living in conflict situations
Libyans desperate to flee violence risk the dangerous crossing to Europe Today, November 2, the Memorandum of Understanding (MoU) on migration between the Italian and Libyan governments will automatically renew for three years. The European
UK IP demands contain provisions that would drastically harm access to affordable, lifesaving generic medicines from India, upon which millions of people around the world rely Negotiations between the United Kingdom (UK) and India on
The World Health Organization (WHO) released today the 2022 edition of its Global Tuberculosis (TB) Report, featuring data on the TB response and trends in 215 countries and areas. Among the alarming trends from 2021, there is
Sign up for our emails and get deeper insight into world and work of MSF!
